When buying an omega-3 supplement, most people look at the total amount of EPA+DHA. But research shows that the EPA:DHA ratio can be just as decisive as the absolute dose. EPA and DHA are both long-chain omega-3 fatty acids, but they have completely different effects in the body. Depending on the health goal — whether cardiovascular health, mental wellbeing, cognitive performance or support during pregnancy — a different ratio may be appropriate. This article explains what lies behind the EPA:DHA ratio, which ratio is recommended for which goal, and what to look for when buying an omega-3 supplement.
What EPA and DHA do in the body
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are both polyunsaturated omega-3 fatty acids of the n-3 series, but their biological roles differ fundamentally. Understanding this is the basis for any sensible discussion of the optimal ratio.
EPA — the inflammation modulator
EPA is an important precursor for the synthesis of so-called eicosanoids — including prostaglandins, thromboxanes and leukotrienes of the 3-series, which, unlike the 2-series eicosanoids formed from arachidonic acid (omega-6), have anti-inflammatory or at least inflammation-neutral effects. By competing with arachidonic acid for the same enzymes (COX and LOX), EPA modulates the balance between pro- and anti-inflammatory signalling molecules. Studies also show that EPA has a significant influence on mood regulation: a 2019 meta-analysis with over 1,200 participants found that supplements with an EPA content of over 60% of total EPA+DHA showed a significantly stronger antidepressant effect than DHA-dominant products (PubMed PMID 30646157).
DHA — the structural component
DHA, on the other hand, is an essential structural component of the body. It makes up 30–40% of the phospholipids in grey brain matter and is present in the retina with a proportion of up to 50% of phospholipid fatty acids. This structural role makes DHA indispensable for neuronal signal transmission, the fluidity of cell membranes and the development of the visual system. The need for DHA is particularly pronounced during foetal development and in the first years of life. According to the EFSA health claim, a daily intake of 250 mg DHA contributes to normal brain and visual function.
Mutual competition for enzymes
An often overlooked aspect: EPA and DHA compete in the body for the same desaturase and elongase enzymes in metabolism. A high EPA level can slightly inhibit DHA synthesis and vice versa. This competition is another reason why the ratio between the two fatty acids — and not just their absolute amounts — is relevant for the physiological effect. Anyone wishing to deliberately achieve a high DHA level should therefore not choose a pure EPA supplement, but a product with a balanced or DHA-dominant ratio. You can learn more about omega-3 metabolism in the body in our article on omega-3 fatty acids and how the body uses them.
Which EPA:DHA ratio for which health goal?
The question of the ideal ratio cannot be answered in blanket terms. However, science provides clear indications of which ratio makes sense for particular health goals. The following overview summarises the current state of research.
Cardiovascular health and triglycerides: balanced 1:1 to 2:1 (EPA:DHA)
For general cardiovascular health, EFSA and most cardiology professional societies recommend a balanced EPA+DHA supplement. Both fatty acids act synergistically on cardiovascular risk factors: EPA lowers triglyceride levels and inhibits platelet aggregation, while DHA improves heart rate variability and lowers blood pressure at higher doses. For normal heart function, 250 mg EPA+DHA daily is sufficient according to EFSA. For elevated triglyceride levels, 2,000–4,000 mg EPA+DHA daily is therapeutically common, with a ratio of 1:1 to 2:1 (EPA:DHA) being the standard. Detailed information on the effect on the heart can be found in our article Omega-3 and heart health.
Mental health, mood and depression: EPA-dominant (2:1 to 3:1)
In mental illnesses such as depression and anxiety disorders, clinical studies show a clear advantage for EPA-dominant formulations. A widely cited meta-analysis by Sublette et al. (2011) showed that omega-3 supplements with at least 60% EPA content (relative to EPA+DHA) had a significantly antidepressant effect, while DHA-dominant products showed no significant effect (PubMed PMID 21939614). A ratio of 2:1 to 3:1 (EPA:DHA) at a daily dose of 1,000–2,000 mg EPA is therefore considered the orientation for this area of application. Read also our detailed article on Omega-3 for depression and low mood.
Brain and cognitive function: DHA-dominant (1:2)
For cognitive health, concentration and overall brain function, the evidence points to DHA as the more important fatty acid. Since DHA makes up the main proportion of omega-3 fatty acids in brain tissue, it makes sense to opt for a DHA-dominant ratio for goals such as memory, concentration and neuroprotective effect. A ratio of 1:2 (EPA:DHA) is a common recommendation here. More in our article Omega-3 and brain function.
Inflammatory conditions and rheumatism: EPA-dominant
In chronic inflammatory conditions such as rheumatoid arthritis or psoriasis, research predominantly uses EPA-dominant preparations (2:1 to 3:1 EPA:DHA). EPA directly competes with arachidonic acid for pro-inflammatory enzymes and thus modulates the production of inflammatory mediators. A Cochrane review confirmed moderate evidence for reduction of joint pain and morning stiffness in rheumatism patients under high omega-3 intake.
Pregnancy and breastfeeding: DHA dominant (≥200 mg DHA + 250 mg EPA)
During pregnancy and breastfeeding, DHA takes absolute priority. EFSA recommends pregnant and breastfeeding women an additional daily intake of 200 mg DHA — in addition to the normal 250 mg EPA+DHA. DHA is crucial for the brain and eye development of the foetus, with DHA requirements being particularly high in the third trimester and in the first months of life. Many pregnancy supplements therefore offer a DHA:EPA ratio of 2:1 or higher. Detailed information can be found in the article Omega-3 in pregnancy.
Eyes and vision: DHA dominant
For eye health and particularly for supporting dry eye conditions, DHA is the more relevant fatty acid. EFSA confirms a health claim for DHA: 250 mg DHA daily contributes to normal visual function. DHA is present in extremely high concentrations in the retina and is needed for the rapid signal transmission in photoreceptors. Algae oil products, which are often DHA-dominant, are particularly well suited here.
| Health goal | Recommended ratio | Minimum daily dose | Focus |
|---|---|---|---|
| General cardiovascular health | 1:1 to 2:1 (EPA:DHA) | 250 mg EPA+DHA | Balanced |
| Elevated triglycerides | 1:1 to 2:1 (EPA:DHA) | 2,000 mg EPA+DHA | Balanced / slightly EPA-dominant |
| Mental health, mood, depression | 2:1 to 3:1 (EPA:DHA) | 1,000–2,000 mg EPA | EPA dominant (≥60% EPA) |
| Brain, cognition | 1:2 (EPA:DHA) | 250 mg DHA | DHA dominant |
| Rheumatism, inflammation | 2:1 to 3:1 (EPA:DHA) | 2,000–3,000 mg EPA+DHA | EPA dominant |
| Pregnancy, breastfeeding | DHA dominant | ≥200 mg DHA + 250 mg EPA | DHA dominant |
| Eyes, vision | DHA dominant | 250 mg DHA | DHA dominant |
Typical EPA:DHA ratios in commercially available products
Knowledge of the optimal ratio is only useful when you relate it to the actual composition of commercially available supplements. There are considerable differences here.
Standard fish oil 18/12 (EPA 18% / DHA 12%)
Classic fish oil in capsules typically contains 18% EPA and 12% DHA, corresponding to a ratio of approximately 1.5:1 (EPA:DHA). A capsule containing 1,000 mg of fish oil therefore provides around 180 mg EPA and 120 mg DHA, i.e. 300 mg EPA+DHA in total. This ratio is adequate for most adults with general health goals, but often insufficient for specific applications such as depression or pregnancy.
Concentrated omega-3 with 60% EPA+DHA and above
Highly concentrated omega-3 supplements contain 60%, 80% or even over 90% EPA+DHA. The ratio varies depending on the manufacturer: some concentrate evenly (e.g. 33% EPA / 22% DHA), while others deliberately emphasise EPA or DHA. When purchasing, it is worth examining the exact composition — not just the overall concentration. Our buying guide for high-quality omega-3 helps you with the selection.
Algae oil: often DHA-dominant
Algae oil is obtained directly from microalgae, the origin of marine omega-3 fatty acids in the food chain. Many commercial algae oil products are DHA-dominant and sometimes contain barely any EPA. For vegans and vegetarians who wish to supplement DHA specifically — for example during pregnancy or for eye health — algae oil is an excellent choice. Those who also depend on sufficient EPA should carefully check the composition or choose an algae oil product that also contains appreciable amounts of EPA.
Pure EPA products (icosapentaenoic acid)
High-dose, pure EPA products (e.g. icosapentaenoic acid ethyl ester, known under the brand name Vascepa) are used in cardiology for severely elevated triglyceride levels and are prescription-only in many countries. They contain no DHA and target specifically the anti-inflammatory and triglyceride-lowering effect of EPA.
Can the body convert EPA into DHA?
A frequent question is whether one can rely on endogenous conversion — i.e. whether a pure EPA supplement is sufficient to also cover DHA requirements.
The answer is: yes, conversion does occur, but to a very small extent. Humans can convert EPA into DHA through several elongase and desaturase steps (so-called retro-conversion). However, studies show that this conversion rate is only approximately 5–9% — too little to fully cover DHA requirements for specific goals such as pregnancy or brain health from EPA alone. Conversely, DHA can be retro-converted to EPA to a limited extent, also with low efficiency.
The conclusion: for specific health goals — particularly during pregnancy, for cognitive goals or for eye health — you should supply DHA deliberately and in sufficient quantities, without relying on endogenous conversion. You can read more about omega-3 metabolism in our foundational article on omega-3 fatty acids: fundamentals and mechanisms of action.
Practical recommendations: what to consider when choosing a product
For the vast majority of healthy adults without a specific health goal, a standard product with an EPA:DHA ratio of 2:1 to 3:2 and at least 250–500 mg EPA+DHA daily is a solid foundation. Anyone pursuing a specific goal should choose the ratio deliberately.
Quick guide: ratio by goal
General health: Standard product 2:1 EPA:DHA (180/120 mg per capsule) is sufficient.
Mental health / mood: EPA-dominant, at least 60% EPA content relative to EPA+DHA.
Brain / cognition: DHA-dominant, 1:2 EPA:DHA or pure DHA supplement.
Pregnancy: Minimum 200 mg DHA + 250 mg EPA daily, DHA-dominant.
Vegans: Choose algae oil, check DHA content.
If you would like to calculate your personal omega-3 requirements, use our Omega-3 Requirements Calculator — it takes into account weight, age, life stage and health goal.
Also bear in mind: the EPA:DHA ratio is only one criterion when choosing a product. Equally important are the overall concentration, purity (heavy metals, PCBs, TOTOX value), bioavailability (triglyceride vs. ethyl ester form) and certifications. Our buying guide for high-quality omega-3 oil covers all these aspects in detail.
For a thorough overview of the individual fatty acids, our detailed articles are also recommended: Getting to know EPA — eicosapentaenoic acid in detail and DHA: effects and importance of docosahexaenoic acid.
EFSA Health Claims: dose references
EFSA has approved the following health claims, which serve as guidance for minimum doses:
— Normal heart function: 250 mg EPA+DHA/day
— Normal brain function: 250 mg DHA/day
— Normal vision: 250 mg DHA/day
— Normal blood pressure: 3,000 mg EPA+DHA/day
— Normal triglyceride levels: 2,000 mg EPA+DHA/day
More information on the EFSA website (Opinion on DHA and EPA).
Frequently asked questions about the EPA:DHA ratio
Is EPA or DHA more important?
Neither EPA nor DHA is fundamentally more important — both fatty acids fulfil different, complementary roles in the body. EPA modulates inflammatory processes and supports mental health, while DHA is indispensable as a structural component in the brain, retina and cell membranes. The question of which is more important always depends on the individual health goal.
Why do some omega-3 products have much more EPA than DHA?
Fish oil naturally contains more EPA than DHA, which is why standard products typically show a ratio of 1.5:1 to 2:1. Some manufacturers deliberately concentrate EPA to serve specific application areas such as mental health or inflammation modulation. Pure EPA products such as icosapentaenoic acid are used primarily for severely elevated triglyceride levels.
What EPA:DHA ratio does EFSA recommend?
EFSA does not issue a specific recommendation for a particular EPA:DHA ratio. It only recommends a daily intake of 250–300 mg EPA+DHA for adults, which corresponds to the EFSA health claim for normal heart function. For specific health goals, the ratio should be individually adjusted.
Do I need a specific EPA:DHA ratio during pregnancy?
Yes. During pregnancy and breastfeeding, a DHA-dominant ratio is recommended, as DHA is particularly important for the brain and eye development of the foetus and infant. According to the EFSA health claim, at least 200 mg of DHA per day is recommended in addition to the normal 250 mg EPA+DHA. Many pregnancy supplements therefore offer a DHA-dominant ratio of 1:2 or higher.
Can I combine EPA and DHA from different sources?
Yes, you can combine EPA and DHA from different sources without any problem, for example fish oil and algae oil. The body utilises both fatty acids regardless of their origin. Pay attention to the total quantity and the resulting ratio, which you can easily calculate by adding together the individual amounts.
Medical Disclaimer
This article is for general information purposes only and does not replace medical advice. All health claims are based on EFSA-approved health claims and published studies.